dCas9: A Versatile Tool for Epigenome Editing
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The epigenome is a heritable layer of information not encoded in the DNA sequence of the genome, but in chemical modifications of DNA or histones. These chemical modifications, together with transcription factors, operate as spatiotemporal regulators of genome activity. Dissecting epigenome function requires controlled site-specific alteration of epigenetic information. Such control can be obtained using designed DNA-binding platforms associated with effector domains to function as targeted transcription factors or epigenetic modifiers. Here, we review the use of dCas9 as a novel and versatile tool for fundamental studies on epigenetic landscapes, chromatin structure and transcription regulation, and the potential of this approach in basic research in these fields.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368 · cited 2×
“Numerous studies have established correlations between epigenetic state and genome activity (Bernstein et al., 2010; Rivera and Ren, 2013; Roadmaps Epigenomics Consortium et al., 2015).”
BackgroundConversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 4×
“repressor domains (KRAB, SID) have been fused to dCas9 to specifically increase or decrease target gene expression (Gilbert et al., 2013; Maeder et al., 2013b; Perez-Pinera et al., 2013; Lawhorn et al., 2014).”
BackgroundInfluentialDNA methylation: roles in mammalian development
Smith, Z. D., & Meissner, A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3354 · Cited by 3,045 · cited 2×
“These states correlate with gene expression and chromatin structure, and link the modification pattern of DNA and histones of genomic regions to states of development and differentiation (Holliday, 2006; Henikoff and Shilatifard, 2011; Zhou et al., 2011; Turner, 2012; Smith and Meissner, 2013).”
BackgroundBird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825 · cited 7×
“The application of dCas9 in forward screening using targeted transcription factors (TTFs) was shown to permit highly specific genome-scale transcription modulation (Gilbert et al., 2014; Konermann et al., 2015).”
BackgroundMethodInfluentialGenome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728 · cited 4×
“The application of dCas9 in forward screening using targeted transcription factors (TTFs) was shown to permit highly specific genome-scale transcription modulation (Gilbert et al., 2014; Konermann et al., 2015).”
MethodInfluentialIn vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
The accessible chromatin landscape of the human genome
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679 · cited 1×
“Characterizing known or discovering new regulatory elements in the genome Large-scale mapping of the human epigenome and chromatin states reveals vast numbers of putative regulatory elements (ENCODE Project Consortium, 2012; Thurman et al., 2012; Roadmaps Epigenomics Consortium et al., 2015).”
BackgroundHigh-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414 · cited 2×
“…of Cas9 for higher PAM specificity (Kleinstiver et al., 2015), reduction of non-specific charge interactions between Cas9 and non-target DNA strand (Slaymaker et al., 2016) or hydrogen bonding between Cas9 and the backbones of the target DNA strand and the sgRNA (Kleinstiver et al., 2016), as well…”
BackgroundCrystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306 · cited 1×
“The use of such small orthologues reduces the size problem with no drawbacks on activity, as observed for a truncated SpyCas9 derivative in which a less-conserved, non-interacting portion of the recognition lobe had been removed (Nishimasu et al., 2014).”
BackgroundGenome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268 · cited 2×
“Off-target binding is related to flexibility in PAM sequence recognition and permitted mismatches in the PAM-distal part of the sgRNA (Kim et al., 2015; Ran et al., 2015; Tsai et al., 2015; Wang et al., 2015b; Leenay et al., 2016).”
BackgroundFunction and information content of DNA methylation
Schübeler, D. (2015) · Nature · doi:10.1038/nature14192 · Cited by 2,060 · cited 2×
“Epigenetic information consists of covalent chemical modifications [post-translational modification of histone proteins that include, but are not limited to, methyl, acetyl, phosphoryl and ubiquitin groups (Turner, 2012) and methylation of cytosine bases (Vardimon et al., 1982; Schübeler, 2015)] that alter the structu…”
BackgroundImproving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 2×
“Studies on target specificity have mainly been done on Cas9 (Fu et al., 2014; Slaymaker et al., 2016; Kleinstiver et al., 2016); these findings can be extrapolated to dCas9 and dCas9-based effectors.”
BackgroundThe NIH Roadmap Epigenomics Mapping Consortium
Bernstein, B. E., Stamatoyannopoulos, J. A., Costello, J. F., Ren, B., Milosavljevic, A., Meissner, A., Kellis, M., Marra, M. A., Beaudet, A. L., Ecker, J. R., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1010-1045 · Cited by 1,892
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752 · cited 4×
“Cas9 has been very rapidly and widely adopted (Doudna and Charpentier, 2014) as tool for genome editing (Cho et al., 2013a; Cong et al., 2013; Hwang et al., 2013; Jinek et al., 2013; Mali et al., 2013b).”
BackgroundMethodInfluentialEngineered CRISPR-Cas9 nucleases with altered PAM specificities
Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, V. V., Nguyen, N. T., Zheng, Z., Gonzales, A. P. W., Li, Z., Peterson, R. T., Yeh, J.-R. J., et al. (2015) · Nature · doi:10.1038/nature14592 · Cited by 1,624 · cited 3×
“Efforts to reduce off-target binding include rational redesign of Cas9 for higher PAM specificity (Kleinstiver et al., 2015), reduction of non-specific charge interactions between Cas9 and non-target DNA strand (Slaymaker et al., 2016) or hydrogen bonding between Cas9 and the backbones of the…”
BackgroundInfluentialHighly efficient Cas9-mediated transcriptional programming
Chavez, A., Scheiman, J., Vora, S., Pruitt, B. W., Tuttle, M., P R Iyer, E., Lin, S., Kiani, S., Guzman, C. D., Wiegand, D. J., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3312 · Cited by 1,622
Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460 · cited 2×
“Another option is dCas9 delivery using in vitro assembled sgRNA(d)Cas9 ribonucleoproteins (RNPs), an approach which was successful for dCas9-VP64 (Zuris et al., 2015) and Cas9 genome editing applications (Cho et al., 2013b; Kim et al., 2014; Ramakrishna et al., 2014; Sun et al., 2015; Zuris et al.,…”
MethodRNA-guided gene activation by CRISPR-Cas9-based transcription factors
Perez-Pinera, P., Kocak, D. D., Vockley, C. M., Adler, A. F., Kabadi, A. M., Polstein, L. R., Thakore, P. I., Glass, K. A., Ousterout, D. G., Leong, K. W., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2600 · Cited by 1,328 · cited 2×
“repressor domains (KRAB, SID) have been fused to dCas9 to specifically increase or decrease target gene expression (Gilbert et al., 2013; Maeder et al., 2013b; Perez-Pinera et al., 2013; Lawhorn et al., 2014).”
BackgroundCRISPR RNA–guided activation of endogenous human genes
Maeder, M. L., Linder, S. J., Cascio, V. M., Fu, Y., Ho, Q. H., & Joung, J. K. (2013) · Nature Methods · doi:10.1038/nmeth.2598 · Cited by 1,249
Charting histone modifications and the functional organization of mammalian genomes
Zhou, V. W., Goren, A., & Bernstein, B. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2905 · Cited by 1,147 · cited 2×
“These states correlate with gene expression and chromatin structure, and link the modification pattern of DNA and histones of genomic regions to states of development and differentiation (Holliday, 2006; Henikoff and Shilatifard, 2011; Zhou et al., 2011; Turner, 2012; Smith and Meissner, 2013).”
BackgroundDNA Recognition by Cys2His2 Zinc Finger Proteins
Wolfe, S. A., Nekludova, L., & Pabo, C. O. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.183 · Cited by 1,053
Thakore, P. I., D'Ippolito, A. M., Song, L., Safi, A., Shivakumar, N. K., Kabadi, A. M., Reddy, T. E., Crawford, G. E., & Gersbach, C. A. (2015) · Nature Methods · doi:10.1038/nmeth.3630 · Cited by 1,012 · cited 3×
“In a different study, in which the KRAB domain was targeted at the HS2 enhancer in the globin locus control region (LCR) in human K562 cells, H3K9me3 marks were effectively introduced at the target enhancer region (Thakore et al., 2015).”
BackgroundDigenome-seq: Genome-wide profiling of CRISPR-cas9 off-target effects in human cells
Kim, D., Bae, S., Park, J., Kim, E., Kim, S., Yu, H. R., Hwang, J., Kim, J.-I., & Kim, J.-S. (2015) · Nature Methods · doi:10.1038/nmeth.3284 · Cited by 992 · cited 1×
“Off-target binding is related to flexibility in PAM sequence recognition and permitted mismatches in the PAM-distal part of the sgRNA (Kim et al., 2015; Ran et al., 2015; Tsai et al., 2015; Wang et al., 2015b; Leenay et al., 2016).”
BackgroundEngineering complex synthetic transcriptional programs with CRISPR RNA scaffolds
Zalatan, J. G., Lee, M. E., Almeida, R., Gilbert, L. A., Whitehead, E. H., La Russa, M., Tsai, J. C., Weissman, J. S., Dueber, J. E., Qi, L. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.11.052 · Cited by 938
CRISPR-Cas Systems in Bacteria and Archaea: Versatile Small RNAs for Adaptive Defense and Regulation
Bhaya, D., Davison, M., & Barrangou, R. (2011) · Annual Review of Genetics · doi:10.1146/annurev-genet-110410-132430 · Cited by 914 · cited 2×
“The CRIPSR-associated protein 9 (Cas9) is an antiviral enzyme of the Type II clustered regularly interspaced short palindromic repeat (CRISPR) adaptive immune system in prokaryotes (Barrangou et al., 2007; Bhaya et al., 2011).”
BackgroundOptical control of mammalian endogenous transcription and epigenetic states
Konermann, S., Brigham, M. D., Trevino, A. E., Hsu, P. D., Heidenreich, M., Cong, L., Platt, R. J., Scott, D. A., Church, G. M., & Zhang, F. (2013) · Nature · doi:10.1038/nature12466 · Cited by 803
Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
Esvelt, K. M., Mali, P., Braff, J. L., Moosburner, M., Yaung, S. J., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2681 · Cited by 786
Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
Kuscu, C., Arslan, S., Singh, R., Thorpe, J., & Adli, M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2916 · Cited by 777 · cited 1×
“Current hurdles in application of dCas9 dCas9 has been shown to exhibit off-target binding at genome-wide scale (Kuscu et al., 2014; Tsai et al., 2015).”
BackgroundParallel single-cell sequencing links transcriptional and epigenetic heterogeneity
Angermueller, C., Clark, S. J., Lee, H. J., Macaulay, I. C., Teng, M. J., Hu, T. X., Krueger, F., Smallwood, S. A., Ponting, C. P., Voet, T., et al. (2016) · Nature Methods · doi:10.1038/nmeth.3728 · Cited by 717
The Discovery of Zinc Fingers and Their Applications in Gene Regulation and Genome Manipulation
Klug, A. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-010909-095056 · Cited by 710 · cited 1×
“These applications of synthetic ZFPs are key examples of an adaptable DNA-binding platform tool, unique at the time, and laid the basis for the use of ZFP fusions in a wide range of applications (Klug, 2010; Urnov et al., 2010; Gersbach et al., 2014).”
BackgroundFunctional annotation of native enhancers with a Cas9–histone demethylase fusion
Kearns, N. A., Pham, H., Tabak, B., Genga, R. M., Silverstein, N. J., Garber, M., & Maehr, R. (2015) · Nature Methods · doi:10.1038/nmeth.3325 · Cited by 656 · cited 4×
“…blockage (Bikard et al., 2013; Qi et al., 2013), gene expression modulation (Cheng et al., 2013; Gilbert et al., 2013), epigenetic editing (Hilton et al., 2015; Kearns et al., 2015) and staining of chromosomal regions for live cell imaging (Chen et al., 2013; Anton et al., 2014; Ma et al., 2015).”
BackgroundInfluentialGene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA
Ramakrishna, S., Kwaku Dad, A.-B., Beloor, J., Gopalappa, R., Lee, S.-K., & Kim, H. (2014) · Genome Research · doi:10.1101/gr.171264.113 · Cited by 655 · cited 1×
“…using in vitro assembled sgRNA(d)Cas9 ribonucleoproteins (RNPs), an approach which was successful for dCas9-VP64 (Zuris et al., 2015) and Cas9 genome editing applications (Cho et al., 2013b; Kim et al., 2014; Ramakrishna et al., 2014; Sun et al., 2015; Zuris et al., 2015; D’Astolfo et al., 2015).”
MethodSelf‐assembled DNA nanoclews for the efficient delivery of CRISPR–Cas9 for genome editing
Sun, W., Ji, W., Hall, J. M., Hu, Q., Wang, C., Beisel, C. L., & Gu, Z. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506030 · Cited by 629 · cited 1×
“…using in vitro assembled sgRNA(d)Cas9 ribonucleoproteins (RNPs), an approach which was successful for dCas9-VP64 (Zuris et al., 2015) and Cas9 genome editing applications (Cho et al., 2013b; Kim et al., 2014; Ramakrishna et al., 2014; Sun et al., 2015; Zuris et al., 2015; D’Astolfo et al., 2015).”
MethodRivera, C. M., & Ren, B. (2013) · Cell · doi:10.1016/j.cell.2013.09.011 · Cited by 550 · cited 2×
“Numerous studies have established correlations between epigenetic state and genome activity (Bernstein et al., 2010; Rivera and Ren, 2013; Roadmaps Epigenomics Consortium et al., 2015).”
BackgroundClassification and evolution of type II CRISPR-Cas systems
Chylinski, K., Makarova, K. S., Charpentier, E., & Koonin, E. V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku241 · Cited by 498 · cited 2×
“Due to the availability of Cas9 orthologues (Chylinski et al., 2014) and redesigned synthetic Cas9 proteins (Kleinstiver et al.”
BackgroundInfluentialHistone modification: cause or cog?
Henikoff, S., & Shilatifard, A. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.06.006 · Cited by 482
Editing the epigenome: technologies for programmable transcription and epigenetic modulation
Thakore, P. I., Black, J. B., Hilton, I. B., & Gersbach, C. A. (2016) · Nature Methods · doi:10.1038/nmeth.3733 · Cited by 451 · cited 1×
“This application has been a major step forward in editing the epigenome (de Groote et al., 2012; Thakore et al., 2016).”
BackgroundWang, X., Wang, Y., Wu, X., Wang, J., Wang, Y., Qiu, Z., Chang, T., Huang, H., Lin, R.-J., & Yee, J.-K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3127 · Cited by 442 · cited 2×
“Off-target binding is related to flexibility in PAM sequence recognition and permitted mismatches in the PAM-distal part of the sgRNA (Kim et al., 2015; Ran et al., 2015; Tsai et al., 2015; Wang et al., 2015b; Leenay et al., 2016).”
BackgroundDevelopment of an intein-mediated split-Cas9 system for gene therapy
Truong, D.-J. J., Kühner, K., Kühn, R., Werfel, S., Engelhardt, S., Wurst, W., & Ortiz, O. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv601 · Cited by 371 · cited 3×
“In both cases, after intein transsplicing is induced full-length functional Cas9 is obtained (Davis et al., 2015; Truong et al., 2015).”
BackgroundGroner, A. C., Meylan, S., Ciuffi, A., Zangger, N., Ambrosini, G., Dénervaud, N., Bucher, P., & Trono, D. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000869 · Cited by 364
Wang, D., Mou, H., Li, S., Li, Y., Hough, S., Tran, K., Li, J., Yin, H., Anderson, D. G., Sontheimer, E. J., et al. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.087 · Cited by 345
In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence
Choo, Y., Sánchez-García, I., & Klug, A. (1994) · Nature · doi:10.1038/372642a0 · Cited by 292 · cited 1×
“Choo et al. (1994) demonstrated in 1994 that it is possible to specifically target an oncogenic gene and reduce its transcription through transcriptional blockage by ZFP.”
BackgroundEpigenetic germline inheritance
Chong, S., & Whitelaw, E. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.09.001 · Cited by 239 · cited 1×
“Epigenetic modification states are dynamic by nature and depend on enzymes transferring or removing these modifications (Holliday, 1987; Cubas et al., 1999; Chong and Whitelaw, 2004; Youngson and Whitelaw, 2008).”
Background
Cited by
Advances in epigenetics link genetics to the environment and disease
Cavalli, G., & Heard, E. (2019) · Nature · doi:10.1038/s41586-019-1411-0 · Cited by 1,509
Clinical epigenetics: seizing opportunities for translation
Berdasco, M., & Esteller, M. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0074-2 · Cited by 498
Regulation of transposable elements by DNA modifications
Deniz, Ö., Frost, J. M., & Branco, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0106-6 · Cited by 486
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
Dimitri, A., Herbst, F., & Fraietta, J. A. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01559-z · Cited by 352
Roca Paixão, J. F., Gillet, F.-X., Ribeiro, T. P., Bournaud, C., Lourenço-Tessutti, I. T., Noriega, D. D., Melo, B. P. D., de Almeida-Engler, J., & Grossi-de-Sa, M. F. (2019) · Scientific Reports · doi:10.1038/s41598-019-44571-y · Cited by 308
Metadata
- Authors
- Brocken, D. J. W., Tark-Dame, M., & Dame, R. T.
- Venue
- Current Issues in Molecular Biology
- Publisher
- MDPI AG
- Published
- 2018
- Volume
- 26
- Pages
- 15-32
- ISSN
- 1467-3037 (ISSN-L)
- OpenAlex
- W2564400416
- Cited by
- 105
- References
- 55
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.